A. Kretzrommel et al., AUTOIMMUNITY CAUSED BY DISRUPTION OF CENTRAL T-CELL TOLERANCE - A MURINE MODEL OF DRUG-INDUCED LUPUS, The Journal of clinical investigation, 99(8), 1997, pp. 1888-1896
A side effect of therapy with procainamide and numerous other medicati
ons is a lupus-like syndrome characterized by autoantibodies directed
against denatured DNA and the (H2A-H2B)-DNA subunit of chromatin. We t
ested the possibility that an effect of lupus-inducing drugs on centra
l T cell tolerance underlies these phenomena. Two intrathymic injectio
ns of procainamide-hydroxylamine (PAHA), a reactive metabolite of proc
ainamide, resulted in prompt production of IgM antidenatured DNA antib
odies in C57BL/6xDBA/2 F1 mice. Subsequently, IgG antichromatin antibo
dies began to appear in the serum 3 wk after the second injection and
were sustained for several months. Specificity, inhibition and blockin
g studies demonstrated that the PAHA-induced antibodies showed remarka
ble specificity to the (H2A-H2B)-DNA complex. No evidence for polyclon
al B cell activation could be detected based on enumeration of Ig-secr
eting B cells and serum Ig levels, suggesting that a clonally restrict
ed autoimmune response was induced by intrathymic PAHA. The IgG isotyp
e of the antichromatin antibodies indicated involvement of T cell help
, and proliferative responses of splenocytes to oligonucleosomes incre
ased up to 100-fold. As little as 5 mu M PAHA led to a 10-fold T cell
proliferative response to chromatin in short term organ culture of neo
natal thymi. We suggest that PAHA interferes with self-tolerance mecha
nisms accompanying T cell maturation in the thymus, resulting in the e
mergence of chromatin-reactive T cells followed by humoral autoimmunit
y.